Thrombectomy Devices Market

Thrombectomy Devices Market, By Product Type (Mechanical Thrombectomy Devices, Aspiration Thrombectomy Devices, Hydrodynamic Thrombectomy Devices, Ultrasonic Thrombectomy Devices), By Application (Deep Vein Thrombosis (DVT), Pulmonary Embolism (PE), Superficial Vein Thrombosis, Renal Vein Thrombosis (RVT), Arterial Thrombosis (Atherothrombosis), Others (Ischemic Stroke, etc.)), By End User (Hospitals, Ambulatory Surgical Centers, Others (Academic and Research Institutes, etc.)), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)

Thrombectomy refers to physical removal of soft thrombus from blood vessels. A thrombectomy device is easy to use, and it consistently opens blood vessels for the removal of blood clots. Use of thrombectomy devices can improve long-term neurological outcomes such as ischemic brain injury and others, by providing higher rates of procedural recanalization. Once recanalization starts, clot softens and partially dissolves, indicating clinical recovery. Thrombectomy devices can be used in patients, where pharmacological treatments such as thrombolysis are likely to be ineffective or inappropriate, in case of recent cardiovascular surgery or in patients taking oral anticoagulants. Mechanical aspiration thrombectomy devices are dual-lumen catheters that are passed across the culprit lesion over a standard 0.014-inch guidewire. Of the two lumens, the smaller lumen consists of the guidewire by using a rapid exchange monorail system. Peripheral thrombectomy is associated with peripheral arterial disease (PAD), acute limb ischemia (ALI), critical limb ischemia (CLI), chronic total occlusion (CTO), deep vein thrombosis (DVT), pulmonary embolism (PE), and other peripheral vascular disease (PVD).

Market Dynamics

Increasing product approvals by regulatory authorities such as U.S. Food and Drug Administration is expected to drive the global thrombectomy devices market growth over the forecast period. For instance, in May 2020, Control Medical Technology, LLC., a medical technology company, announced that the U.S. Food and Drug Administration had approved Aspire MAX 7 – 11F mechanical thrombectomy system that is designed to remove blood clots from the peripheral vessels. The Aspire MAX 7 – 11F mechanical thrombectomy system includes (20) new large-lumen, flexible, and kink-resistant catheters w/dilators powered by the Aspire Aspirator and/or an electromechanical pump.

Key features of the study:

• This report provides an in-depth analysis of the global thrombectomy devices market and provides market size (US$ Bn) and compound annual growth rate (CAGR) for the forecast period (2023–2030), considering 2022 as the base year It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
• It profiles key players in the global thrombectomy y devices market based on the following parameters– company highlights, products portfolio, key highlights, financial performance, and strategies.
• Key companies covered as a part of this study include Boston Scientific Corporation, Medtronic, Merit Medical System Inc., Stryker Corporation, Terumo Corporation, Teleflex Incorporated, Vetex Medical Ltd., Edwards Lifesciences Corporation, Penumbra Inc., Control Medical Technology, LLC., Rapid Medical, Abbott and Surmodics, Inc.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• Global thrombectomy devices market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global thrombectomy devices market

Thrombectomy Devices Market Detailed Segmentation:

• By Product Type:
• Mechanical Thrombectomy Devices
• Aspiration Thrombectomy Devices
• Hydrodynamic Thrombectomy Devices
• Ultrasonic Thrombectomy Devices
• By Application:
• Deep Vein Thrombosis (DVT)
• Pulmonary Embolism (PE)
• Superficial Vein Thrombosis
• Renal Vein Thrombosis (RVT)
• Arterial Thrombosis (Atherothrombosis)
• Others (Ischemic Stroke, etc.)
• By End User:
• Hospitals
• Ambulatory Surgical Centers
• Others (Academic and Research Institutes, etc)
• By Region:
• North America
• Latin America
• Europe
• Asia Pacific
• Middle East
• Africa
• Company Profiles
• Boston Scientific Corporation*
• Medtronic
• Merit Medical System Inc.
• Stryker Corporation
• Terumo Corporation
• Teleflex Incorporated
• Vetex Medical Ltd.
• Edwards Lifesciences Corporation
• Penumbra Inc.
• Control Medical Technology, LLC.
• Rapid Medical
• Abbott
• Surmodics, Inc.